Public preview. Funding rounds, founders, and growth signals require a free account.

GALECTIN THERAPEUTICS INC (GALT)

Clinical-stage biopharma developing therapies for fibrotic diseases, MASH cirrhosis, and cancer.

SeedPharmaNorcross, GA

Total raised

$4.5M

Last round

Equity

$3.0M · Dec 2016

Stage

Seed

Status

Active

Founders & team

Co-founder, CEO

Co-founder, CTO

Head of Engineering

Head of Sales

🔒

Free account unlocks founder names, LinkedIn profiles, and prior companies.

Web traffic

Search interest

Social followers

Glassdoor rating

News mentions

Gov contracts

🔒

Free account unlocks 5 full profiles per day. Pro removes the limit.

Get notified the moment GALECTIN THERAPEUTICS INC (GALT) files a new round, hires execs, or shows traction signals.

About this data

FlareSight surfaces funding data from SEC Form D filings within hours of submission. Browse our full startup funding database to find more recently funded companies.